论文信息 - Influence Diagnostics of a Region of Interest in Multi-regional Clinical Trials - 字舞流文

Influence Diagnostics of a Region of Interest in Multi-regional Clinical Trials

Kazuhiko Kuribayashi | C. Cao

[1] Shuangzhe Liu,et al. Regression diagnostics , 2020, Applied Quantitative Analysis for Real Estate.

[2] S. Chow,et al. On evaluation of consistency in multi-regional clinical trials , 2018, Journal of biopharmaceutical statistics.

[3] R. Finkel,et al. Nusinersen versus Sham Control in Later‐Onset Spinal Muscular Atrophy , 2018, The New England journal of medicine.

[4] Hiroyuki Uesaka,et al. Sample Size Allocation to Regions in a Multiregional Trial , 2009, Journal of biopharmaceutical statistics.

[5] Hsiao-Hui Tsou,et al. Use of Prior Information for Bayesian Evaluation of Bridging Studies , 2007, Journal of biopharmaceutical statistics.

[6] S. Chow,et al. Reproducibility probability in clinical trials , 2002, Statistics in medicine.

[7] Shein-Chung Chow,et al. ASSESSING SENSITIVITY AND SIMILARITY IN BRIDGING STUDIES , 2002, Journal of biopharmaceutical statistics.

[8] W. Shih,et al. Clinical trials for drug registrations in Asian-Pacific countries: proposal for a new paradigm from a statistical perspective. , 2001, Controlled clinical trials.

[9] David A. Belsley,et al. Regression Diagnostics: Identifying Influential Data and Sources of Collinearity , 1980 .

[10] Ich Harmonised,et al. INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE , 2006 .